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Mechanisms of acute retroviral pathogenesis have been examined during primary infection of rhesus macaques with
simian–human immunodeficiency virus 89.6PD (SHIV89.6PD). During acute infection, between initial exposure and establish-
ment of antigen-specific immune responses that stabilize the virus burden, rapid immune system changes influence the viral
set-point and dictate subsequent steps in disease progression. In a previous study, we described specific patterns of
lymphocyte activation during acute SHIV89.6PD infection. We now extend these studies to describe lymphoid tissue activation,
using whole body positron emission tomography (PET) and the radioactive tracer 2-[18F]fluorodeoxyglucose (FDG). Within a
few days after primary infection by intravenous, intrarectal, or intravaginal routes, PET–FDG imaging revealed a distinct
pattern of lymphoid tissue activation centered on axillary, cervical, and mediastinum lymph nodes. Increased tissue FDG
uptake preceded fulminant virus replication at these sites, suggesting that a diffusible factor of host or viral origin was
responsible for lymphoid tissue changes. These data show that activation of lymphoid tissues in the upper body is an early
response to virus infection and that diffusible mediators of activation might be important targets for vaccine or therapeutic
intervention strategies. © 2000 Academic PressKey Words: simian–human immunodeficiency virus; acute infection; pathogenesis; AIDS; positron emission tomography
imaging.
INTRODUCTION
Acute infection identifies the interval between human
immunodeficiency virus type 1 transmission and the ap-
pearance of antigen-specific immune responses. Ac-
companying clinical sequelae comprise a common acute
retroviral syndrome that is characterized by flu-like
symptoms, including rash and nightsweats (Clark et al.,
1991; Tindall and Cooper, 1991). The severity and dura-
tion of acute retroviral syndrome have been linked to
subsequent rates for disease progression (Pedersen et
al., 1989; Schacker et al., 1998). When virus-specific
CD41 T-cell helper and CD81 T-cell cytotoxic responses
rise early and at high levels, acute disease is less
evere and the prognosis is more favorable (Musey et
l., 1997; Rosenberg et al., 1997; Kalams and Walker,
1998). The virus burden fluctuates during primary human
immunodeficiency virus (HIV) infection until viral RNA
(vRNA) levels stabilize during the stage of persistent
infection and become predictive for the time to AIDS
1 Present address: Institute of Human Virology, Baltimore, MD 21201.
2 To whom reprint requests should be addressed at: Institute ofHuman Virology, University of Maryland Biotechnology Institute, 725 W.
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255(Henrard et al., 1995; Schacker et al., 1998). We believe
that the earliest host–virus interactions act to limit the
effectiveness of immune responses and thus dictate the
viral set-point and subsequent disease progression (Wal-
lace et al., 1999). Our study of acute retroviral pathogen-
esis seeks to characterize mechanisms unique to this
interval and to identify early targets for therapeutic inter-
vention.
We model the acute infection interval by using rhesus
macaques inoculated with the chimeric simian–human
immunodeficiency virus 89.6PD (SHIV89.6PD). Infection
with this pathogenic virus depletes peripheral blood and
lymphoid tissue CD41 T cells by 1 month after inocula-
tion, and these animals manifest high virus burden and
declining B-cell numbers (Steger et al., 1998; Lu et al.,
1998; Wallace et al., 1999) with correspondingly low lev-
els of neutralizing antibodies (Crawford et al., 1999).
Studies of the earliest events after mucosal inoculation,
when virus was not yet detected in blood or peripheral
lymphoid tissues, showed that T cells were already de-
fective and had lost the lymphoproliferative response to
mitogen (Steger et al., 1999; Wallace et al., 1999). The
loss of mitogen responses is a marker for rapid progres-
sion (Wallace et al., unpublished observations) and re-
flects the fact that CD41 T cells from acutely infected
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ACE ETmacaques were driven to apoptosis by phytohemagglu-
tinin stimulation in vitro. An investigation of activation
markers on these peripheral blood CD41 T cells showed
increased surface expression of CD25 (interleukin-2 re-
ceptor a chain), the early activation marker CD69, and
HLA-DR. Together, these observations indicate that in-
appropriate cell signaling leading to activation-induced
cell death may account for the hyporesponsiveness to
mitogen in vitro and may contribute to the rapid depletion
of CD41 T cells in vivo. In the studies mentioned above,
the patterns of cellular activation were defined mainly
with purified cells from peripheral blood (Wallace et al.,
1999). Our goals now are to discern the anatomical
locations where lymphocyte activation is prominent, to
show whether acute infection is associated with a de-
fined pattern of tissue responses, and to compare these
patterns for several routes of infection.
The use of whole body positron emission tomography
(PET) imaging with radioactive 2-[18F]fluorodeoxyglucose
FDG) has been instrumental in identifying tumors or
ther foci of increased metabolic activity (Moon et al.,
998). In HIV-positive persons, PET scanning has helped
o discriminate between central nervous system lym-
homa and inflammatory toxoplasmosis lesions in the
rain (Hoffman et al., 1993; O’Doherty et al., 1997). PET
tudies initiated to identify tumors showed that both
enign lymph nodes (LNs) undergoing inflammation and
ranulomatous sites in persons with various diseases of
nfectious or other origin often have elevated FDG up-
ake, as reviewed by Shreve et al. (1999) and Coleman et
l. (1999).
We reported previously that whole body PET of SIV-
nfected macaques injected with the FDG radiotracer
ighlighted activated lymphoid tissues and produced a
ap of the host responses to persistent virus infection
uring middle- and late-stage disease (Scharko et al.,
996). Here, we use PET scanning to look at lymphoid
issue activation during the interval of SHIV89.6PD acute
nfection of rhesus macaques. We are cautious that the
apid nature of SHIV89.6PD infection in rhesus macaques
may not directly parallel the time course of pathogenic
events of HIV infection in humans. However, we have
established that virological and immunological changes
during acute infection are determinative for disease pro-
gression rates (Steger et al., 1998, 1999; Wallace et al.,
1999), and we hypothesize that a similar relationship
holds for HIV-1 infection in humans. Based on our imag-
ing experiments, during acute infection, we noted re-
markably similar patterns for LN activation after three
different routes of SHIV89.6PD inoculation. Further, we ob-
served that LN activation precedes fulminant virus rep-
lication in a key set of LNs in the upper body. These data
show that lymphoid tissue activation precedes wide-
256 WALLscale virus dissemination or acute viremia, and tissue
activation may be a key step in SHIV pathogenesis.
i
eRESULTS
Six rhesus macaques were infected with SHIV89.6PD and
sed to study early host–virus interactions. Macaques
4074 and 94089 were inoculated intravenously (IV), ma-
aques 94079 and 94077 were inoculated intrarectally
IR), and macaques 94069 and 92071 were inoculated
ntravaginally (IVAG). Animals were subjected to PET
maging to observe lymphoid tissue activation that oc-
urred during the first few weeks after inoculation. Ma-
aque 94074 was PET scanned on day 3 after inoculation
nd was euthanized on day 4. Macaque 94089 was
canned on days 3 and 7 after inoculation and was
uthanized on day 8. Macaques 94079 and 94069 were
canned on day 7 after inoculation and were euthanized
n day 8. Macaques 94077 and 92071 were scanned on
ays 7 and 14 after inoculation and were euthanized on
ay 15.
Euthanasia and necropsy were performed on the
orning after the last PET scan, and lymphoid tissues
ere collected. In a previous publication (Wallace et al.,
999), we reported CD41 and CD81 T-cell subset data, a
ummary table of SHIV RNA in situ hybridization results,
nd mitogen responses for these samples. For the in situ
ybridization, if no positive cells were detected in five
igh-powered fields, then the tissue samples were con-
idered negative for SHIV RNA.
V inoculated macaques
Macaque 94074 was euthanized 4 days after IV inoc-
lation; vRNA was not detected with in situ hybridization
n axillary, cervical, or inguinal LNs. The range of lym-
hocytes from axillary, cervical, inguinal, ileocecal, mes-
nteric, or iliac LNs that were CD41 T cells was 36–54%
ith a mean of 47% (Wallace et al., 1999). These values
are comparable to the percentage of CD41 T cells
resent in LNs of healthy, uninfected macaques (Sopper
t al., 1997; Schenkel et al., 1999). The pattern of FDG
ptake on day 3 was visualized by PET imaging in ma-
aque 94074 and was similar to that of an uninfected
acaque, with greater areas of activity in the brain,
eart, and bladder (normal distribution). A weaker thy-
us signal was also visible as a triangular shape above
nd to the right of the heart (Fig. 1A). FDG uptake in all of
hese organs is observed commonly in uninfected rhe-
us macaques, and FDG in the bladder was due to
ormal excretion and accumulation of the radiotracer
espite urinary catheterization (Scharko et al., 1996). We
sed the day 3 time point because the kinetics for IV
nfection are more rapid than for mucosal inoculation. We
id not observe substantial lymphoid tissue activation in
his animal by day 3, possibly because the time point
as too soon after inoculation.
Macaque 94089 was euthanized eight days after IV
AL.nfection; vRNA was detected in axillary, ileocecal, mes-










































ACUTEintestine and thymus. By day 8, this animal lost 79% of
circulating CD41 T cells; blood and tissue lymphocytes
ere not responsive to mitogen stimulation (Wallace et
l., 1999). The range of LN lymphocytes that were CD41
T cells was 13–34% with a mean of 22%, which is less
than the average percentage of CD41 T cells present in
LNs of healthy uninfected macaques but within the nor-
mal range (Veazey et al., 1997; Schenkel et al., 1999). This
macaque was scanned on days 3 and 7 after infection.
On day 3, macaque 94089 had high FDG uptake in the
cervical, axillary, and mediastinum LNs (Fig. 1B). On day
7, the FDG uptake in the cervical and axillary LNs re-
mained at high levels (Fig. 1C).
IR inoculated macaques
Macaque 94079 was euthanized 8 days after IR inoc-
FIG. 1. Selected coronal planes of PET–FDG images for SHIV89.6PD-
infected macaques. The animal number, day after infection, and route
of infection are indicated for each image.
PET IMAGING OFulation; vRNA was not detected in axillary, ileocecal, and
inguinal LNs or thymus (Figs. 2A–2D) or in mesenteric
w
2LN, spleen, and rectum (not shown). The range of LN
CD41 lymphocytes was 42–54% with a mean of 49%;
owever, the macaque had lost 62% of circulating CD41
T cells, and the T cells were not responsive to mitogen
stimulation (Wallace et al., 1999). Macaque 94079 was
PET scanned on day 7 after IR inoculation and showed
FDG uptake in the cervical and axillary LNs, in addition
to lower-intensity FDG uptake in the hilar and mediasti-
num LN areas (Fig. 1D). These results suggest that one
of the earliest markers associated with acute infection,
the loss of T lymphocyte responsiveness to mitogen, is
temporally correlated with upper body LN activation that
was observed with PET imaging. Our observations par-
allel the finding of increased activation marker expres-
sion on peripheral blood CD41 T cells from SHIV89.6PD-
noculated macaques during acute infection (Wallace et
l., 1999). Tissue histopathology showed that the axillary,
leocecal, and inguinal LNs were well populated with
ymphocytes and that the cortex regions contained active
ollicles with germinal centers (Figs. 2A–2C). These ob-
ervations are consistent with normal LN architecture
Chan and Tsang, 1996). However, the increased FDG
ptake in axillary and cervical LNs of macaque 94079 at
days after infection (Fig. 1D) may be an early indicator
f incipient follicular hyperplasia, the first stage of immu-
odeficiency virus-associated lymphadenopathy (Racz et
l., 1986).
Macaque 94077, which was euthanized on day 15 after
R infection, was scanned on both days 7 and 14. On day
, macaque 94077 had high FDG uptake in cervical,
xillary, and mediastinum LNs (Fig. 1E). Five distinct foci
f FDG uptake appeared in the abdominal cavity and
ay represent active gut associated lymphoid tissues or
bdominal LNs but had much lower signal intensity than
he upper body LN sites. On day 14, when macaque
4077 was scanned a second time, FDG uptake in the
ervical and axillary LNs was decreased compared with
ay 7, although these signals were still clearly visible
Fig. 1F). By 15 days after infection, explosive follicular
yperplasia of LNs (Racz et al., 1986) was apparent with
umerous and sometimes irregularly shaped secondary
ollicles. Many of the follicles had mantle zone alter-
tions, some of which aberrantly protruded into the ger-
inal centers (Figs. 2E–2G). In situ hybridization for
RNA using day-15 tissue samples from macaque 94077
emonstrated widespread dissemination of virus. For
xample, the axillary and inguinal LNs from macaque
4077 showed dispersed and distinct hybridization sig-
als throughout the paracortical region and cortex that
ere consistent with infection of individual cells (Figs. 2E
nd 2G). In situ hybridization of ileocecal LNs showed
egions of intense staining inside some of the germinal
enters (Fig. 2F). The distribution of viral RNA in the
hymus of macaque 94077 was restricted to the medulla,
257SHIV INFECTIONith a noticeable absence of infection in the cortex (Fig.





























wn).was 9–15% with a mean of 12% (below normal levels);
lymphocytes isolated from LNs of macaque 94077 were
not responsive to mitogen, and this macaque had lost
96% of circulating CD41 T cells by day 15 after infection
(Wallace et al., 1999).
IVAG inoculated macaques
Macaque 94069, which was euthanized 8 days after
IVAG infection, was scanned on day 7 and looked very
similar to the day-7 IR infected macaques in showing
significantly elevated FDG uptake in the cervical and
axillary LNs, along with distinct signals for mediastinum
and hilar LN (Fig. 1G). vRNA was not detected in axillary,
cervical, ileocecal, or inguinal LNs but was present in
mesenteric LN and cecum. The range of CD41 LN lym-
phocytes was 39–60% with a mean of 47%, which is
similar to healthy, uninfected macaques. However, this
macaque had lost 39% of circulating CD41 T cells by day
after infection due to a sharp drop in peripheral blood
ymphocyte count. Lymphocytes from macaque 94069 at
ay 8 were not responsive to mitogen (Wallace et al.,
999). These findings show again that LN activation
easured by PET–FDG is associated with lymphocyte
onresponsiveness to mitogenic stimulation measured
n vitro. In macaque 94069 at day 8 after IVAG inocula-
ion, all regions of axillary, inguinal, cervical, and mes-
nteric LNs were appropriately populated with lympho-
ytes and contained follicles with prominent germinal
enters but were not dramatically hyperplastic (data not
hown). Together, these observations again suggest that
ctivation of LNs as visualized by PET–FDG may be
redictive for the ensuing follicular hyperplasia and
bundant virus replication.
Macaque 92071, which was euthanized 15 days after
VAG inoculation, was imaged on days 7 and 14. Similar
FIG. 2. In situ hybridization for SHIV RNA from indicated tissue spe
94079) or day 15 (E–H from macaque 94077) after IR infection. LN s
photographed at 103 magnification. Positive hybridization to SHIV RNA
Control (sense probe) hybridization specimens were negative (not sho
258 WALLo the other day-7 mucosally infected macaques, ma-
aque 92071 showed intense signals in the cervical andxillary LNs along with activity in mediastinum and hilar
N areas (Fig. 1H). At day 14, macaque 92071 still had
ery strong cervical and axillary LN signals (Fig. 1I). In
itu hybridization for macaque 92071 demonstrated
idespread dissemination of virus in all tissues exam-
ned 15 days after infection. The range of CD41 LN
lymphocytes was 2–5% with a mean of 4%. The remain-
ing LN lymphocytes from macaque 92071 were not re-
sponsive to mitogen (Wallace et al., 1999). This macaque
had lost 94% of circulating CD41 T cells by day 15 after
nfection. The intensity of PET–FDG signals in cervical
nd axillary LNs despite the near-complete depletion of
D41 T cells suggests either that a small number of cells
can give rise to intense signals or that cells other than
CD41 T cells also take up FDG in these activated LNs. In
a previous study, we reported that a majority of FDG
uptake in activated LN mononuclear cells occurred in
B-lymphocytes (Scharko et al., 1996).
DISCUSSION
Before our studies of the macaque model for AIDS
(Scharko et al., 1996), whole body PET scanning has not
been used to study lymphoid tissue activation in re-
sponse to viral infection. Previously, we had used PET
imaging in a well-established SIV infection model to
evaluate lymphoid tissue activation patterns during per-
sistent infection (Scharko et al., 1996). Here we used the
same imaging technology to elucidate patterns of tissue
activation in our acute infection model that uses SHIV in
macaques.
We had used whole body PET imaging to study lym-
phoid tissue activation in SIV-infected rhesus macaques,
based on the idea that lymphocyte activation in tissues
was both a normal response to virus and necessary to
support productive virus replication (Scharko et al., 1996).
of SHIV89.6PD-infected macaques at either day 8 (A–D from macaque
s are photographed at 253 magnification, and thymus samples are
aled by brown dots on the nuclear fast red staining (pink) background.
AL.cimens
ample
ACE ETPET images of SIV-infected macaques showed disease-
















































ACUTEpresent in controls. Macaques with mid-stage SIV infec-
tion had activated axillary, cervical, mesenteric, and ileo-
cecal LN. Macaques with late-stage disease had meta-
bolically active ileocecal LN and other gut associated
lymphoid tissue activation. Such terminally infected ani-
mals lacked metabolically active axillary and cervical
nodes, consistent with the collapse of LN architecture
that is associated with late-stage disease (Racz et al.,
986; Pantaleo et al., 1994).
In the present study, PET scans of acutely infected
rhesus macaques showed a reproducible pattern of met-
abolically active axillary and cervical LN within the first 2
weeks after inoculation. Regardless of whether virus was
introduced into macaques by IV, IR, or IVAG inoculation,
LNs in the cervical and axillary regions were the first to
appear in these images. The kinetics of LN activation
differed among the three routes as might be expected.
Events observed by 1 week after IV inoculation were
apparent only by around 2 weeks after mucosal inocu-
lation. This finding is consistent with our previous reports
that plasma virus burdens peak earlier after IV than after
mucosal SHIV89.6PD inoculation (Lu et al., 1998). In studies
f SIV infection by IV or IR routes, we observed similar
ifferences in early kinetics and significant differences in
he length of survival depending on the route for virus
noculation (Pauza et al., 1994, 1998; Trivedi et al., 1996).
We observed repeatedly that acute SHIV89.6PD infection
is associated with the loss of in vitro T-cell responses to
mitogen. The loss of T-cell function occurred as much as
1 week before vRNA was abundant in tissues and before
CD41 T-cell depletion (Steger et al., 1999; Wallace et al.,
999). Whole body PET–FDG imaging revealed the cor-
elation between early activation of cervical and axillary
Ns and the first loss of in vitro mitogen responses due
to activation-induced cell death. Lymphoproliferative re-
sponses to mitogen were low in five of six animals from
this study, and all five had distinct patterns of lymphoid
tissue activation in their PET scans. In contrast, mitogen
responses were normal for lymphocytes from uninfected
controls or from macaque 94074, where the PET scan
was similar to controls and showed no activated lym-
phoid tissues.
We see strong parallels between the kinetics of
early LN activation observed by PET imaging and the
kinetics of cellular activation seen in our previous
studies of acute infection (Wallace et al., 1999). The LN
activation seen by PET was apparent before detect-
able levels of viral replication in these nodes. This
finding indicates that lymphoid tissue cells may be
stimulated by some early herald of viral infection,
perhaps a diffusible viral protein or cytokine(s) se-
creted at a distant site of focal virus replication. Al-
though we did not look specifically at the jejunum,
others have reported that this tissue is an important
PET IMAGING OFsite for acute virus replication (Veazey et al., 1998), and
soluble factors could be released from there. The
g
tHIV-1 Tat protein, an early product of immunodefi-
ciency virus infection, is a prime suspect for causing
the early activation of lymphoid cells because Tat is
released readily from HIV-1-infected cells (Ensoli et
al., 1990), it causes lymphocyte activation in vitro (Wes-
tendorp et al., 1995; Blazquez et al., 1999), and it
activates CD95 L (Fas ligand) expression (Cohen et al.,
1999). Importantly, Tat also increases chemokine re-
ceptor levels both in vitro (Huang et al., 1998; Secchi-
ero et al., 1999) and in vivo (Pauza et al., 2000).
PET imaging has been used successfully to localize
umors and foci of bacterial or fungal infection in HIV-
ositive persons (O’Doherty et al., 1997). To date, there
re no published studies of PET imaging in acutely
IV-infected persons; however, two cases studied in our
enter indicated a very similar pattern of FDG uptake in
xillary and cervical LNs (Pauza et al., unpublished ob-
ervations). Our macaque studies show that upper body
Ns were critically involved in acute infection, regardless
f the route for inoculation. Localized activation of lym-
hoid tissues was correlated with in vitro susceptibility to
ctivation-induced cell death, and tissue activation pre-
eded fulminant virus replication. These phenomena
uggest that the initial wave of lymphoid tissue activation
ncreases host susceptibility to virus and promotes dis-
emination to all peripheral lymphoid tissues. Activation
as most rapid after IV infection, suggesting that access
o the blood compartment is a critical step in acute
athogenesis.
The identification of specific LNs and their roles in
cute SHIV pathogenesis raises important questions
bout the unique properties of individual sites within the
econdary lymphoid tissues. Although it is common to
nterpret LN function only in terms of “draining” one
natomical region and to assume that all LNs are func-
ionally equivalent, there are important examples of lo-
ally unique properties. Transgenic mice deficient for
xpression of the CXCR5 (BLR1) chemokine receptor
acked inguinal LNs and had few intact Peyer’s patch
tructures, despite the normal appearance of many other
econdary lymphoid tissues, including axillary, mesen-
eric, and popliteal LNs (Fo¨rster et al., 1996). Diseases of
he lymphoid system are also often localized, with the
mportant examples of Hodgkin’s disease, which fre-
uently presents as enlarged upper body LNs, or Bur-
itt’s lymphoma, which arises more commonly in the
bdomen. These examples and the PET–FDG data pre-
ented here suggest that the early patterns and kinetics
f lymphoid tissue involvement are crucial to acute
athogenesis. The mechanisms for activation of specific
issues, possibly involving regulation of unique chemo-
ines and/or their receptors, should constitute new tar-
259SHIV INFECTIONets for therapeutic intervention during acute HIV infec-
ion.
ACE ETMATERIALS AND METHODS
Animals and viral infections
Six captive bred juvenile rhesus macaques (Macaca
mulatta) were housed at the Wisconsin Regional Primate
Research Center (WRPRC) and used in these studies.
The WRPRC is accredited by the American Academy of
Laboratory Animal Care. All animal research protocols
were approved by the Institutional Animal Care and Use
Committee. Macaques were immobilized with ketamine
hydrochloride (10 mg/kg body wt) before all virus inocu-
lations and blood collections. General Medical Labora-
tories (Madison, WI) performed automated complete
blood cell counts (CBCs) on all samples. Two macaques
were infected IV in the saphenous vein with 25 tissue
culture infectious doses (TCID) SHIV89.6PD (provided by Dr.
Yichen Lu, Virus Research Institute, Boston, MA), two
macaques were infected IR with 2500 TCID, and two
macaques were infected IVAG with 25,000 TCID.
PET imaging
PET imaging of SHIV89.6PD-infected rhesus macaques
was performed as described previously (Scharko et al.,
1996). IV infected animals were imaged on day 3 or 7
after infection, and mucosally infected animals were im-
aged on day 7 or 14 after infection.
Tissue collection and processing
To investigate virus dissemination, lymphocyte subset
distribution, and immune function of blood and tissue
lymphocytes during acute infection, animals were sacri-
ficed within 15 days after inoculation. The IV infected
animals were euthanized on day 4 or 8 after infection.
One animal from each of the mucosally infected groups
was euthanized on day 8 or 15 after infection. After the
administration of ketamine hydrochloride, blood was
drawn and the animals were euthanized by the IV ad-
ministration of 0.1 ml/kg body wt pentobarbital sodium
and phenytoin sodium (Beuthanasia; Schering-Plough
Animal Health, Kenilworth, NJ). At necropsy, LNs, spleen,
thymus, ileum, cecum, and rectum were harvested,
among other tissues. Paraffin-embedded tissue blocks
used for histopathology and in situ hybridization were
prepared from portions of these tissues.
Localization of viral RNA by in situ hybridization
In situ hybridization for vRNA used a pool of digoxige-
nin-labeled RNA probes generated by Sp6 or T7 poly-
merase transcription from the entire genome of both
SIVmac239 and HIV-1bh10. The detailed method was de-
scribed previously (Hirsch et al., 1995; Wallace et al.,
1999).
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